カテゴリ： GlobalData, アメリカ, 企業調査

Humana Inc (HUM)：製薬・医療：M&Aディール及び事業提携情報

◆英語タイトル：Humana Inc (HUM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード：DATA904C9898
◆発行会社（調査会社）：GlobalData
◆発行日：2018年11月
◆ページ数：79
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Humana Inc (Humana) is a health and well-being company that offers health insurance and Medicare plans, insurance products, and health and wellness services to healthcare providers, employers, individuals, administrators, government, and the public sector. The company’s Medicare products and services include Medicare Advantage plan, prescription drug plan, Medicare supplement insurance plans, group Medicare advantage plan and Medicare plan tools. It offers products and services for individual and family including medical plans, dental plans, vision plans, life insurance and life and supplemental plans, among others. The company sells its products in the US through direct sales representatives and telemarketing representatives, licensed independent brokers and agents and marketing arrangement with Wal-Mart Stores Inc. Humana is headquartered in Louisville, Kentucky, the US.

Humana Inc (HUM) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Humana Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Humana Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Humana Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Humana Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Humana Inc, Medical Devices Deals, 2012 to YTD 2018 10
Humana Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Humana Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Omada Health Raises USD48 Million in Series C Financing 12
Private Equity 14
TPG Capital, Welsh, Carson, Anderson & Stowe and Humana Acquires 100% Stake in Kindred Healthcare for USD4.1 Billion 14
Partnerships 17
Allergan Enters into Research Agreement with Humana 17
Humana Enters Into Research Agreement With Astellas For Health Care Delivery 18
Humana Enters Into Research Agreement With Novo Nordisk For Diabetes 19
Equity Offering 20
Metropolitan Health Files Registration Statement For Public Offering Of Securities For US$200 Million 20
Acquisition 21
MJ Acquisition Acquires Concentra for USD1 Billion 21
Humana Acquires Your Home Advantage 23
Humana Acquires Svenska Specialistpsykiatrigruppen From Valedo Partners 24
Humana Acquires American Eldercare, Healthcare Services Provider 25
Humana Completes Acquisition Of Metropolitan Health Networks For US$850 Million 26
Metcare of Florida To Acquire Kanner, Shteiman, Provider Of Healthcare Services 28
Humana Completes Acquisition Of SeniorBridge Family Companies From Caltius Equity Partners 29
Humana Inc – Key Competitors 30
Humana Inc – Key Employees 31
Humana Inc – Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Recent Developments 37
Strategy And Business Planning 37
May 10, 2017: Humana Brings Value-Based Orthopedic Specialty Care to North Carolina and Virginia 37
Financial Announcements 38
Aug 17, 2018: Humana announces results of second quarter 2018 and interim period January-June 2018 38
Aug 01, 2018: Humana reports second quarter 2018 financial results 39
May 16, 2018: Humana: Results of First Quarter 2018 41
May 02, 2018: Humana releases Q1 2018 results 42
Nov 08, 2017: Humana Reports Third Quarter 2017 Financial Results 43
Aug 02, 2017: Humana Reports Second Quarter 2017 Financial Results; Raises Full Year 2017 Guidance; Provides Update on Bonus Year 2018 Star Ratings 45
May 03, 2017: Humana Reports Detailed First Quarter Financial Results; Reaffirms Recent Full-Year 2017 EPS Guidance Increase 46
Apr 24, 2017: Humana Pre-announces First Quarter 2017 EPS and Revenues and Increases Full-year 2017 EPS Guidance 47
Feb 08, 2017: Humana Reports Fourth Quarter 2016 Financial Results 48
Corporate Communications 51
Sep 14, 2018: Humana Foundation donates $250,000 for hurricane florence local disaster relief and recovery efforts 51
Mar 27, 2018: Humana Names Matt Berger as Regional President 52
Jan 16, 2018: Luis A. Torres Olivera Named Puerto Rico Market President for Humana 53
Nov 13, 2017: Humana Elects Karen DeSalvo, M.D., to Board of Directors 54
Aug 21, 2017: Humana appoints new member to board of directors 55
Jun 23, 2017: Humana Names Sam Deshpande Chief Risk Officer 56
Government and Public Interest 57
Jul 18, 2017: Humana Foundation Awards $735,000 to South Florida Nonprofits to Improve Health of Community 57
Product News 59
Dec 06, 2017: New Humana Tool Aims to Improve Medication Management and Safety 59
May 31, 2018: Humana Launches Comprehensive Individual Dental Plan for Those Transitioning from Previous Coverage 60
Feb 02, 2017: Study Finds Omada Diabetes Prevention Program Resulted in 7.5% Weight Loss in Humana Medicare Advantage Population 61
Jan 24, 2018: Humana Innovation Challenge Discovers New Ways to Solve Health Care and User-experience Problems for the Medicare Population 62
Other Significant Developments 63
Oct 17, 2018: For First Time, Humana Offering Medicare Advantage Plans in New Jersey 63
Oct 09, 2018: Humana’s 2019 Medicare Health Plans emphasize choice, affordability and convenience to care for the whole person 64
Oct 03, 2018: Humana and Vancouver Clinic team up in SW Washington to provide medicare advantage beneficiaries access to two new neighborhood clinics 66
Oct 01, 2018: Cleveland Clinic and Humana expand availability of co-branded $0 premium medicare advantage HMO Health Plan in Northeast Ohio 67
Sep 12, 2018: Iora Health and Humana expand relationship to provide more Humana Medicare advantage Plan members access to improved care in Arizona, Georgia and Washington 69
Sep 12, 2018: Humana’s value-based orthopedic specialty care now available in more than one-third of the nation with expansion to the Southwest and Northeast 71
Apr 25, 2018: Humana Launches National Hospital Incentive Program to Improve Patient Experience and Health Outcomes for Humana Commercial Group Members 73
Apr 18, 2018: Humana Launches National Value-Based Model for Maternity Care 74
Apr 12, 2018: Humana Expands Availability of Value-Based Orthopedic Specialty Care to Improve Patient Experience in Seven Additional States 75
Oct 26, 2017: New Study Finds Healthy Days Valid Tool for Evaluating Population Health in Medicare Advantage Patients with Chronic Conditions 77
Oct 17, 2017: Humana Expands Medicare Advantage Offerings in New Hampshire 78
Appendix 79
Methodology 79
About GlobalData 79
Contact Us 79
Disclaimer 79

List of Tables
Humana Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Humana Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Humana Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Humana Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Humana Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Humana Inc, Medical Devices Deals, 2012 to YTD 2018 10
Humana Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Omada Health Raises USD48 Million in Series C Financing 12
TPG Capital, Welsh, Carson, Anderson & Stowe and Humana Acquires 100% Stake in Kindred Healthcare for USD4.1 Billion 14
Allergan Enters into Research Agreement with Humana 17
Humana Enters Into Research Agreement With Astellas For Health Care Delivery 18
Humana Enters Into Research Agreement With Novo Nordisk For Diabetes 19
Metropolitan Health Files Registration Statement For Public Offering Of Securities For US$200 Million 20
MJ Acquisition Acquires Concentra for USD1 Billion 21
Humana Acquires Your Home Advantage 23
Humana Acquires Svenska Specialistpsykiatrigruppen From Valedo Partners 24
Humana Acquires American Eldercare, Healthcare Services Provider 25
Humana Completes Acquisition Of Metropolitan Health Networks For US$850 Million 26
Metcare of Florida To Acquire Kanner, Shteiman, Provider Of Healthcare Services 28
Humana Completes Acquisition Of SeniorBridge Family Companies From Caltius Equity Partners 29
Humana Inc, Key Competitors 30
Humana Inc, Key Employees 31
Humana Inc, Other Locations 32
Humana Inc, Subsidiaries 35

List of Figures
Humana Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Humana Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Humana Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Humana Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Humana Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Humana Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Humana Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Humana Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Humana Inc, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Humana Inc (HUM)：製薬・医療：M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Medipines Corp：医療機器：M&Aディール及び事業提携情報
    Summary MediPines Corp (Medipines) is a provider of respiratory measurement technology products. The company develops portable and non-invasive devices based on pulse oximetry technology. The company’s lead product candidate, Oxistimulator, is a respiratory depression prevention device. Its Oxistimu …
  • Novartis AG (NOVN)：企業の財務・戦略的SWOT分析
    Novartis AG (NOVN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • IXYS Corporation (IXYS)：企業の財務・戦略的SWOT分析
    IXYS Corporation (IXYS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Victorian WorkCover Authority：企業の戦略的SWOT分析
    Victorian WorkCover Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Sun Resources NL (SUR)：石油・ガス：M&Aディール及び事業提携情報
    Summary Sun Resources NL (Sun Resources) is an oil and gas exploration and development company. The company explores and develops crude oil and natural gas. Its services include exploration, production, and development of unconventional oil and gas resources. Its projects include Delta Oil Project, …
  • Neuralstem Inc：企業のM&A・事業提携・投資動向
    Neuralstem Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Neuralstem Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Cyclopharm Ltd (CYC)-医療機器分野：企業M&A・提携分析
    Summary Cyclopharm Ltd (Cyclopharm) is a radiopharmaceutical company that manufactures medical and healthcare equipment and components in the nuclear medicine business. The company’s products include Technegas, a lung imaging device used to diagnose the presence of blood clots in the lungs; and posi …
  • MicroPort Scientific Corp (853)：医療機器：M&Aディール及び事業提携情報
    Summary MicroPort Scientific Corp (MicroPort) a subsidiary of Otsuka Medical Devices Co Ltd is a medical device company which develops, manufactures and markets cardiovascular treatment devices. The company provides products such as cardiovascular devices, orthopedic devices, endovascular devices, e …
  • Petrol dd Ljubljana (PETG)：企業の財務・戦略的SWOT分析
    Petrol dd Ljubljana (PETG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • The Tokyo Star Bank Ltd：企業の戦略・SWOT・財務情報
    The Tokyo Star Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary The Tokyo Star Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Thai Rubber Latex Corp (Thailand) Public Co Ltd (TRUBB)：企業の財務・戦略的SWOT分析
    Thai Rubber Latex Corp (Thailand) Public Co Ltd (TRUBB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’ …
  • Strand Life Sciences Pvt Ltd：医療機器：M&Aディール及び事業提携情報
    Summary Strand Life Sciences Pvt Ltd (Strand Life) is a healthcare technology company that develops offers bioinformatics and clinical diagnostic software products. The company offers bioinformatics software for most analytics platforms such as microarrays, mass spectrometry, next generation sequenc …
  • Natcore Technology Inc (NXT)：電力：M&Aディール及び事業提携情報
    Summary Natcore Technology Inc (Natcore) is a solar research and development company that provides products for semiconductor and fiber optic applications. The company’s products include solar cell structures and black silicon cells. It uses liquid phase deposition technology for controlling deposit …
  • Aurora Diagnostics LLC：製薬・医療：M&Aディール及び事業提携情報
    Summary Aurora Diagnostics LLC (Aurora Diagnostics) is a healthcare service provider that offers hospital and pathology services. The center’s pathology services include gastrointestinal pathology services, heamato-pathology services, dermatology services, urologic pathology, pathology consultation, …
  • Trustpower Ltd：企業の戦略的SWOT分析
    Trustpower Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Jagatjit Industries Limited：企業の戦略・SWOT・財務情報
    Jagatjit Industries Limited - Strategy, SWOT and Corporate Finance Report Summary Jagatjit Industries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Bristol-Myers Squibb Company：企業のM&A・事業提携・投資動向
    Bristol-Myers Squibb Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bristol-Myers Squibb Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • CIRCOR Aerospace Products Group：企業の戦略・SWOT・財務分析
    CIRCOR Aerospace Products Group - Strategy, SWOT and Corporate Finance Report Summary CIRCOR Aerospace Products Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • INEOS Olefins & Polymers Europe：企業の戦略的SWOT分析
    INEOS Olefins & Polymers Europe - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Osprey Medical Inc (OSP)：医療機器：M&Aディール及び事業提携情報
    Summary Osprey Medical Inc (Osprey Medical) is a medical device company that designs, develops, and manufacturers proprietary devices and monitoring systems. The company offers contrast removal system, which is designed to provide cardiologists with an advanced level of CIN protection in high risk p …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆